We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

70 hedge funds and large institutions have $79.3M invested in BioDelivery Sciences International, Inc. in 2017 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 4

47% more call options, than puts

Call options by funds: $311K | Put options by funds: $211K

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

13% more funds holding

Funds holding: 62 → 70 (+8)

9% more capital invested

Capital invested by funds: $73M → $79.3M (+$6.3M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
70
Holders Change
+8
Holders Change %
+12.9%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
22
Reduced
16
Closed
4
Calls
$311K
Puts
$211K
Net Calls
+$100K
Net Calls Change
-$39K

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$6.83M
2
RA
Royce & Associates
New York
+$1.54M
3
BC
Broadfin Capital
New York
+$617K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$416K
5
Millennium Management
Millennium Management
New York
+$290K

Top Sellers

Rank Fund Capital Flow
1
EI
EAM Investors
California
-$2.3M
2
Deutsche Bank
Deutsche Bank
Germany
-$1.16M
3
SCM
Stonepine Capital Management
Oregon
-$613K
4
JGC
J. Goldman & Co
New York
-$398K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$359K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Broadfin Capital
New York
$13.7M +$617K +223,253 +5%
SCM
2
Stonepine Capital Management
Oregon
$10.8M -$613K -221,909 -6%
ACA
3
Avoro Capital Advisors
New York
$7.29M +$6.83M +2,469,488 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.98M +$139K +50,283 +2%
RA
5
Royce & Associates
New York
$5.45M +$1.54M +555,800 +43%
William Blair & Company
6
William Blair & Company
Illinois
$4.4M -$17.3K -6,242 -0.4%
Ameriprise
7
Ameriprise
Minnesota
$3.86M -$339K -122,450 -9%
BlackRock
8
BlackRock
New York
$3.44M +$22.7K +8,204 +0.7%
GPGA
9
Grandeur Peak Global Advisors
Utah
$3.06M -$295K -106,850 -9%
Bank of Montreal
10
Bank of Montreal
Ontario, Canada
$2.9M +$42.2K +15,260 +2%
HP
11
Hikari Power
Japan
$1.77M – – –
B
12
Bailard
California
$1.65M – – –
Geode Capital Management
13
Geode Capital Management
Massachusetts
$1.36M – – –
Renaissance Technologies
14
Renaissance Technologies
New York
$1.35M -$352K -127,300 -22%
GCP
15
GSA Capital Partners
United Kingdom
$1.21M – – –
Jacobs Levy Equity Management
16
Jacobs Levy Equity Management
New Jersey
$1.09M +$416K +150,347 +68%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$765K – – –
BBA
18
Baker Bros. Advisors
New York
$620K – – –
SC
19
Searle & Co
Connecticut
$543K +$2.49K +900 +0.5%
Northern Trust
20
Northern Trust
Illinois
$459K -$2.69K -972 -0.6%
Deutsche Bank
21
Deutsche Bank
Germany
$456K -$1.16M -420,615 -73%
Morgan Stanley
22
Morgan Stanley
New York
$410K +$15.1K +5,454 +4%
ARTA
23
A.R.T. Advisors
New York
$401K +$179K +64,700 +91%
KF
24
Krilogy Financial
Missouri
$395K – – –
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$352K -$359K -129,726 -52%
1
2 3

BDSI Hedge Fund Activity: Q4 2017 in Review

70 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q4 2017, worth a combined $79.3M — up 8.6% from $73M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BDSI positions and 4 closed out — a net gain of 8 holders — while 22 added to existing stakes and 16 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $6.83M. The largest seller was EAM Investors, exiting entirely with an estimated $2.3M sold.

  • 70 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q4 2017, up from 62 in Q3 2017.
  • Funds reported $79.3M of BioDelivery Sciences International, Inc. stock for Q4 2017, up 8.6% quarter-over-quarter.
  • 12 funds opened new BioDelivery Sciences International, Inc. positions in Q4 2017 and 4 closed out, a net change of +8 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q4 2017 was Avoro Capital Advisors, an estimated $6.83M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q4 2017 was EAM Investors, an estimated $2.3M sold.

Based on aggregated 13F filings for Q4 2017.